نتائج البحث - "Haruki Kobayashi"

1

Impact of angiogenesis inhibitor eligibility on the prognosis of patients with non‐small cell lung cancer harboring EGFR mutation

المؤلفون: Taichi Miyawaki, Shota Omori, Naoya Nishioka, Michitoshi Yabe, Toshiaki Takahashi, Akifumi Notsu, Haruki Kobayashi, Akira Ono, Tateaki Naito, Kazushige Wakuda, Eriko Miyawaki, Takanori Kawabata, Haruyasu Murakami, Hiroaki Kodama, Nobuaki Mamesaya, Hirotsugu Kenmotsu

المصدر: Cancer Medicine
Cancer Medicine, Vol 10, Iss 21, Pp 7503-7513 (2021)

مصطلحات موضوعية: Oncology, non‐small cell lung cancer, Male, Cancer Research, medicine.medical_specialty, Multivariate analysis, Lung Neoplasms, Combination therapy, Angiogenesis Inhibitors, medicine.disease_cause, chemistry.chemical_compound, Exon, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Radiology, Nuclear Medicine and imaging, epidermal growth factor tyrosine kinase inhibitor, Lung cancer, Protein Kinase Inhibitors, RC254-282, Research Articles, Aged, Retrospective Studies, Mutation, vascular endothelial growth factor, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Clinical Cancer Research, medicine.disease, Prognosis, Progression-Free Survival, Angiogenesis inhibitor, respiratory tract diseases, Vascular endothelial growth factor, Clinical trial, ErbB Receptors, angiogenesis inhibitor, chemistry, Female, business, Gene Deletion, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c11d98d386565a9f7e941bcf0ae41b2dTest
http://europepmc.org/articles/PMC8559472Test

2

Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study

المؤلفون: Naoya Nishioka, Eriko Miyawaki, Masahiro Endo, Shota Omori, Tateaki Naito, Kazuhisa Takahashi, Taichi Miyawaki, Haruki Kobayashi, Nobuaki Mamesaya, Haruyasu Murakami, Hideyuki Harada, Akira Ono, Ryo Ko, Hirotsugu Kenmotsu, Kazushige Wakuda, Toshiaki Takahashi, Keita Mori, Hiroaki Kodama

المصدر: BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)

مصطلحات موضوعية: Male, Oncology, Cancer Research, Lung Neoplasms, Neoplasm, Residual, Time Factors, Disease, Logistic regression, Failure pattern, Surgical oncology, Carcinoma, Non-Small-Cell Lung, Osimertinib, Treatment Failure, Epidermal growth factor receptor, RC254-282, Aged, 80 and over, Aniline Compounds, biology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Gefitinib, Middle Aged, ErbB Receptors, Disease Progression, Female, Adult, medicine.medical_specialty, Adenocarcinoma, Afatinib, Erlotinib Hydrochloride, EGFR-TKI, Internal medicine, Oligo-residual disease, Genetics, medicine, Humans, Lung cancer, Protein Kinase Inhibitors, Aged, Retrospective Studies, Acrylamides, business.industry, Research, Retrospective cohort study, Genes, erbB-1, medicine.disease, respiratory tract diseases, Logistic Models, Mutation, biology.protein, business, Non-small-cell lung cancer, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0968df06432ca7c42481def3e798a1Test
https://doi.org/10.1186/s12885-021-08983-2Test

3

Characterization of tumour mutation burden in patients with non‐small cell lung cancer and interstitial lung disease

المؤلفون: Tetsuya Mizuno, Mitsuhiro Isaka, Keiichi Ohshima, Haruki Kobayashi, Masatoshi Kusuhara, Hideaki Kojima, Kenichi Urakami, Yasuhisa Ohde, Tateaki Naito, Toshiaki Takahashi, Masakuni Serizawa, Ken Yamaguchi, Hayato Konno, Masahiro Endo, Takeshi Nagashima

المصدر: Respirology (Carlton, Vic.)

مصطلحات موضوعية: Adult, Male, Pulmonary and Respiratory Medicine, Oncology, non‐small cell lung cancer, medicine.medical_specialty, Lung Neoplasms, Adenocarcinoma, medicine.disease_cause, behavioral disciplines and activities, Interstitial Lung Disease, 03 medical and health sciences, 0302 clinical medicine, tumour mutation burden, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, interstitial lung diseases, 030212 general & internal medicine, Lung cancer, Aged, Retrospective Studies, Pneumonitis, Aged, 80 and over, Mutation, Univariate analysis, business.industry, Interstitial lung disease, Middle Aged, respiratory system, medicine.disease, respiratory tract diseases, body regions, lung cancer, 030228 respiratory system, Cardiothoracic surgery, Concomitant, Multivariate Analysis, Carcinoma, Squamous Cell, Female, Original Article, ORIGINAL ARTICLES, Lung Diseases, Interstitial, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7ccf027bda05680946dd0a402586c94Test
http://europepmc.org/articles/PMC7496253Test

4

Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis

المصدر: Investigational new drugs. 39(6)

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, Kaplan-Meier Estimate, Tyrosine-kinase inhibitor, Sex Factors, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Pharmacology (medical), Osimertinib, Epidermal growth factor receptor, Lung cancer, Protein Kinase Inhibitors, Aged, Retrospective Studies, Pharmacology, Aged, 80 and over, biology, business.industry, Age Factors, Middle Aged, medicine.disease, respiratory tract diseases, ErbB Receptors, biology.protein, Female, Erlotinib, Non small cell, business, Meningeal Carcinomatosis, Leptomeningeal metastasis, medicine.drug, Epidermal growth factor receptor tyrosine kinase

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b234eceaed54f034e73b11c7b39f0ea5Test
https://pubmed.ncbi.nlm.nih.gov/34259953Test

5

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

المؤلفون: Akira Ono, Hideyuki Harada, Haruyasu Murakami, Yasuhiro Gon, Kazushige Wakuda, Shota Omori, Tateaki Naito, Haruki Kobayashi, Masahiro Endo, Toshiaki Takahashi, Nobuaki Mamesaya, Hirotsugu Kenmotsu

المصدر: Radiation Oncology (London, England)
Radiation Oncology, Vol 16, Iss 1, Pp 1-9 (2021)

مصطلحات موضوعية: lcsh:Medical physics. Medical radiology. Nuclear medicine, Adult, Male, medicine.medical_specialty, Lung Neoplasms, Limited-stage small-cell lung cancer, lcsh:R895-920, medicine.medical_treatment, Interstitial lung disease, lcsh:RC254-282, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Interstitial lung abnormalities, Medicine, Radiology, Nuclear Medicine and imaging, 030212 general & internal medicine, Lung cancer, Aged, Retrospective Studies, Chemotherapy, Univariate analysis, Lung, business.industry, Incidence, Research, Incidence (epidemiology), Chemoradiotherapy, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prognosis, medicine.disease, Small Cell Lung Carcinoma, respiratory tract diseases, Radiation Pneumonitis, Survival Rate, Radiation therapy, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Female, Lung Diseases, Interstitial, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8179f5937c6a09cab26d17aa332f1c57Test
https://doi.org/10.1186/s13014-021-01780-yTest

6

Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases

المؤلفون: Yoko Nakasu, Eriko Miyawaki, Yasuhiro Gon, Toshiaki Takahashi, Shota Omori, Masahiro Endo, Hirotsugu Kenmotsu, Haruki Kobayashi, Akira Ono, Keita Mori, Takahisa Kawamura, Koichi Mitsuya, Haruyasu Murakami, Hideyuki Harada, Kazushige Wakuda, Kazuhisa Nakashima, Tateaki Naito, Nobuaki Mamesaya

المصدر: International Journal of Radiation Oncology*Biology*Physics. 104:604-613

مصطلحات موضوعية: Male, Oncology, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Kaplan-Meier Estimate, Tyrosine-kinase inhibitor, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Epidermal growth factor receptor, Aged, 80 and over, Radiation, biology, Brain Neoplasms, digestive, oral, and skin physiology, Hazard ratio, Gefitinib, Radiotherapy Dosage, Middle Aged, Progression-Free Survival, ErbB Receptors, Treatment Outcome, 030220 oncology & carcinogenesis, Disease Progression, Female, Non small cell, Adult, medicine.medical_specialty, medicine.drug_class, Antineoplastic Agents, Afatinib, Radiosurgery, Erlotinib Hydrochloride, 03 medical and health sciences, Internal medicine, Confidence Intervals, medicine, Humans, Radiology, Nuclear Medicine and imaging, Lung cancer, Protein Kinase Inhibitors, Aged, Proportional Hazards Models, Retrospective Studies, business.industry, medicine.disease, Confidence interval, respiratory tract diseases, Radiation therapy, stomatognathic diseases, Mutation, biology.protein, Cranial Irradiation, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1bbc6ffcca7f9c1fdb60d6fb23f132Test
https://doi.org/10.1016/j.ijrobp.2019.02.051Test

7

Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation

المؤلفون: Hirotsugu Kenmotsu, Haruyasu Murakami, Tateaki Naito, Takahisa Kawamura, Shota Omori, Keita Mori, Kazushige Wakuda, Haruki Kobayashi, Kazuhisa Nakashima, Akira Ono, Toshiaki Takahashi, Masahiro Endo

المصدر: Investigational New Drugs

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Lung Neoplasms, 0302 clinical medicine, Non-small cell lung cancer, Malignant effusion, Epidermal growth factor, Carcinoma, Non-Small-Cell Lung, Pharmacology (medical), Osimertinib, Aged, 80 and over, Aniline Compounds, Middle Aged, Prognosis, ErbB Receptors, Survival Rate, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Female, Adult, medicine.medical_specialty, Short Report, Antineoplastic Agents, 03 medical and health sciences, EGFR-TKI, Internal medicine, medicine, Humans, Lung cancer, Aged, Retrospective Studies, Pharmacology, Acrylamides, Lung, business.industry, medicine.disease, Confidence interval, Pleural Effusion, Malignant, respiratory tract diseases, 030104 developmental biology, Drug Resistance, Neoplasm, Egfr mutation, Mutation, business, Progressive disease, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9bc8bb2c0ffe3932f6105917cbca7c8Test
https://doi.org/10.1007/s10637-019-00808-1Test

8

Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma

المؤلفون: Naoya Nishioka, Kazushige Wakuda, Taichi Miyawaki, Tateaki Naito, Eriko Miyawaki, Michitoshi Yabe, Akira Ono, Masahiro Endo, Toshiaki Takahashi, Shota Omori, Haruyasu Murakami, Haruki Kobayashi, Takahisa Kawamura, Hirotsugu Kenmotsu, Hiroaki Kodama, Nobuaki Mamesaya

المصدر: Investigational new drugs. 39(2)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Lung Neoplasms, medicine.drug_class, Antineoplastic Agents, behavioral disciplines and activities, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Carcinoma, Humans, Pharmacology (medical), Osimertinib, Adverse effect, Aged, Retrospective Studies, Pharmacology, Aged, 80 and over, Acrylamides, Aniline Compounds, business.industry, Interstitial lung disease, Cancer, Retrospective cohort study, respiratory system, Middle Aged, medicine.disease, respiratory tract diseases, Discontinuation, body regions, ErbB Receptors, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, Lung Diseases, Interstitial

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75ad6be975b9d74603b9a46914901ce1Test
https://pubmed.ncbi.nlm.nih.gov/32955628Test

9

Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy

المؤلفون: Kazushige Wakuda, Hirotsugu Kenmotsu, Keita Mori, Kazuhisa Takahashi, Taichi Miyawaki, Akifumi Notsu, Tateaki Naito, Yasuhisa Ohde, Hideyuki Harada, Haruyasu Murakami, Shota Omori, Haruki Kobayashi, Akira Ono, Nobuaki Mamesaya, Eriko Miyawaki, Masahiro Endo, Toshiaki Takahashi

المصدر: Cancer Science

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lung Neoplasms, non–small‐cell lung cancer, oligometastatic disease, Systemic therapy, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Clinical Research, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Neoplasm Metastasis, Lung cancer, threshold number of metastases, Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, Receiver operating characteristic, business.industry, pattern of progressive disease, Hazard ratio, Area under the curve, Retrospective cohort study, General Medicine, Odds ratio, Middle Aged, medicine.disease, respiratory tract diseases, platinum‐based chemotherapy, 030104 developmental biology, 030220 oncology & carcinogenesis, Disease Progression, Female, Original Article, Neoplasm Recurrence, Local, business, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51912a77c282eb3313ab48292ab44654Test
https://pubmed.ncbi.nlm.nih.gov/33098119Test

10

Impact of prior ALK-tyrosine kinase inhibitor on pemetrexed-based chemotherapy in patients with advanced ALK positive non-small cell lung cancer

المؤلفون: Haruyasu Murakami, Taichi Miyawaki, Toshiaki Takahashi, Shota Omori, Haruki Kobayashi, Eriko Miyawaki, Naoya Nishioka, Akira Ono, Nobuaki Mamesaya, Michitoshi Yabe, Hirotsugu Kenmotsu, Hiroaki Kodama, Tateaki Naito, Kazushige Wakuda

المصدر: Journal of Clinical Oncology. 39:e21113-e21113

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b352a88cb91eb88a47de525ba9784d97Test
https://doi.org/10.1200/jco.2021.39.15_suppl.e21113Test

تنقيح النتائج